Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow

Amy R. Broumas, Rachel E Pollard, Susannah H. Bloch, Erik R Wisner, Stephen M Griffey, Katherine W. Ferrara

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: We evaluated implanted rat mammary adenocarcinoma tumors during a 5-week period using ultrasound, computed tomography (CT), and histology. Materials and Methods: Contrast-enhanced ultrasound with a destruction- replenishment imaging scheme was used to derive estimates of blood volume and flow. These ultrasound-derived measures of microvascular physiology were compared with contrast-enhanced CT-derived measures of perfusion and vascular volume made by the Mullani-Gould formula and Patlak analysis, respectively. Results: The tumor cross-sectional area and necrotic core cross-sectional area determined by the 3 methods were correlated (r2 > 0.8, P < 0.001, n = 15). The spatial integral of perfusion estimated by CT correlated with the spatial integral of flow from ultrasound (P < 0.05). The contrast-enhanced tumor area calculated from the ultrasound analysis was highly correlated with the contrast-enhanced area estimated by CT images (r2 = 0.89, P < 0.001, n = 15). However, the fraction of the tumor area enhanced by the CT contrast agent was significantly larger than either the fraction enhanced by ultrasound contrast agent or than the viable area as estimated from histology slides. Conclusion: Destruction-replenishment ultrasound provides valuable information about the spatial distribution of blood flow and vascular volume in tumors and ultrasound analysis compares favorably with a validated contrast-enhanced CT method.

Original languageEnglish (US)
Pages (from-to)134-147
Number of pages14
JournalInvestigative Radiology
Volume40
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

Tomography
Contrast Media
Neoplasms
Blood Vessels
Histology
Perfusion
Blood Volume
Tumor Burden
Adenocarcinoma
Breast Neoplasms

Keywords

  • Contrast-enhanced CT
  • Destruction-replenishment ultrasound
  • Perfusion
  • Tumor blood flow

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow. / Broumas, Amy R.; Pollard, Rachel E; Bloch, Susannah H.; Wisner, Erik R; Griffey, Stephen M; Ferrara, Katherine W.

In: Investigative Radiology, Vol. 40, No. 3, 03.2005, p. 134-147.

Research output: Contribution to journalArticle

@article{49bef933ed5e409485591d0b46b5557c,
title = "Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow",
abstract = "Objective: We evaluated implanted rat mammary adenocarcinoma tumors during a 5-week period using ultrasound, computed tomography (CT), and histology. Materials and Methods: Contrast-enhanced ultrasound with a destruction- replenishment imaging scheme was used to derive estimates of blood volume and flow. These ultrasound-derived measures of microvascular physiology were compared with contrast-enhanced CT-derived measures of perfusion and vascular volume made by the Mullani-Gould formula and Patlak analysis, respectively. Results: The tumor cross-sectional area and necrotic core cross-sectional area determined by the 3 methods were correlated (r2 > 0.8, P < 0.001, n = 15). The spatial integral of perfusion estimated by CT correlated with the spatial integral of flow from ultrasound (P < 0.05). The contrast-enhanced tumor area calculated from the ultrasound analysis was highly correlated with the contrast-enhanced area estimated by CT images (r2 = 0.89, P < 0.001, n = 15). However, the fraction of the tumor area enhanced by the CT contrast agent was significantly larger than either the fraction enhanced by ultrasound contrast agent or than the viable area as estimated from histology slides. Conclusion: Destruction-replenishment ultrasound provides valuable information about the spatial distribution of blood flow and vascular volume in tumors and ultrasound analysis compares favorably with a validated contrast-enhanced CT method.",
keywords = "Contrast-enhanced CT, Destruction-replenishment ultrasound, Perfusion, Tumor blood flow",
author = "Broumas, {Amy R.} and Pollard, {Rachel E} and Bloch, {Susannah H.} and Wisner, {Erik R} and Griffey, {Stephen M} and Ferrara, {Katherine W.}",
year = "2005",
month = "3",
doi = "10.1097/01.rli.0000152833.35744.7f",
language = "English (US)",
volume = "40",
pages = "134--147",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow

AU - Broumas, Amy R.

AU - Pollard, Rachel E

AU - Bloch, Susannah H.

AU - Wisner, Erik R

AU - Griffey, Stephen M

AU - Ferrara, Katherine W.

PY - 2005/3

Y1 - 2005/3

N2 - Objective: We evaluated implanted rat mammary adenocarcinoma tumors during a 5-week period using ultrasound, computed tomography (CT), and histology. Materials and Methods: Contrast-enhanced ultrasound with a destruction- replenishment imaging scheme was used to derive estimates of blood volume and flow. These ultrasound-derived measures of microvascular physiology were compared with contrast-enhanced CT-derived measures of perfusion and vascular volume made by the Mullani-Gould formula and Patlak analysis, respectively. Results: The tumor cross-sectional area and necrotic core cross-sectional area determined by the 3 methods were correlated (r2 > 0.8, P < 0.001, n = 15). The spatial integral of perfusion estimated by CT correlated with the spatial integral of flow from ultrasound (P < 0.05). The contrast-enhanced tumor area calculated from the ultrasound analysis was highly correlated with the contrast-enhanced area estimated by CT images (r2 = 0.89, P < 0.001, n = 15). However, the fraction of the tumor area enhanced by the CT contrast agent was significantly larger than either the fraction enhanced by ultrasound contrast agent or than the viable area as estimated from histology slides. Conclusion: Destruction-replenishment ultrasound provides valuable information about the spatial distribution of blood flow and vascular volume in tumors and ultrasound analysis compares favorably with a validated contrast-enhanced CT method.

AB - Objective: We evaluated implanted rat mammary adenocarcinoma tumors during a 5-week period using ultrasound, computed tomography (CT), and histology. Materials and Methods: Contrast-enhanced ultrasound with a destruction- replenishment imaging scheme was used to derive estimates of blood volume and flow. These ultrasound-derived measures of microvascular physiology were compared with contrast-enhanced CT-derived measures of perfusion and vascular volume made by the Mullani-Gould formula and Patlak analysis, respectively. Results: The tumor cross-sectional area and necrotic core cross-sectional area determined by the 3 methods were correlated (r2 > 0.8, P < 0.001, n = 15). The spatial integral of perfusion estimated by CT correlated with the spatial integral of flow from ultrasound (P < 0.05). The contrast-enhanced tumor area calculated from the ultrasound analysis was highly correlated with the contrast-enhanced area estimated by CT images (r2 = 0.89, P < 0.001, n = 15). However, the fraction of the tumor area enhanced by the CT contrast agent was significantly larger than either the fraction enhanced by ultrasound contrast agent or than the viable area as estimated from histology slides. Conclusion: Destruction-replenishment ultrasound provides valuable information about the spatial distribution of blood flow and vascular volume in tumors and ultrasound analysis compares favorably with a validated contrast-enhanced CT method.

KW - Contrast-enhanced CT

KW - Destruction-replenishment ultrasound

KW - Perfusion

KW - Tumor blood flow

UR - http://www.scopus.com/inward/record.url?scp=14244259795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14244259795&partnerID=8YFLogxK

U2 - 10.1097/01.rli.0000152833.35744.7f

DO - 10.1097/01.rli.0000152833.35744.7f

M3 - Article

VL - 40

SP - 134

EP - 147

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 3

ER -